Development of a Microflow Digital Imaging Assay to Characterize Protein Particulates During Storage of a High Concentration IgG1 Monoclonal Antibody Formulation-Reference-Cited by-同舟云学术

Development of a Microflow Digital Imaging Assay to Characterize Protein Particulates During Storage of a High Concentration IgG1 Monoclonal Antibody Formulation

Published:2010-08 Issue:8 Volume:99 Page:3343-3361
ISSN:0022-3549
Container-title:Journal of Pharmaceutical Sciences
language:en
Short-container-title:Journal of Pharmaceutical Sciences

Author:

Wuchner Klaus,Büchler Jochen,Spycher Rene,Dalmonte Paul,Volkin David B.

Publisher

Elsevier BV

Subject

Pharmaceutical Science

Reference45 articles.

1. Overlooking subvisible particles in therapeutic protein products: Gaps that may compromise product quality;Carpenter;J Pharm Sci,2009

2. Challenges in the development of high protein concentration formulations;Shire;J Pharm Sci,2004

3. Measuring and increasing protein solubility;Trevino;J Pharm Sci,2008

4. Protein aggregation: Pathways, induction factors, and analysis;Mahler;J Pharm Sci,2009

5. Effects of protein aggregates: An immunologic perspective;Rosenberg;AAPS J,2006

Cited by 87 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A rapid method to monitor structural perturbations of high-concentrated therapeutic antibody solutions using Intrinsic Tryptophan Fluorescence Emission spectroscopy;European Journal of Pharmaceutics and Biopharmaceutics;2024-08

2. In-Situ Monitoring of Protein Degradation in Therapeutic Antibody Formulations Using Intrinsic Tryptophan Fluorescence Emission Spectroscopy;2024

3. Optimization of Flow Imaging Microscopy Setting Using Spherical Beads with Optical Properties Similar to Those of Biopharmaceuticals;Journal of Pharmaceutical Sciences;2023-12

4. The Strengths of Total Holographic Video Microscopy in Detecting Sub-Visible Protein Particles in Biopharmaceuticals: A Comparison to Flow Imaging and Resonant Mass Measurement;Journal of Pharmaceutical Sciences;2023-04

5. Particles in Biopharmaceutical Formulations, Part 2: An Update on Analytical Techniques and Applications for Therapeutic Proteins, Viruses, Vaccines and Cells;Journal of Pharmaceutical Sciences;2021-12